March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Report: Dabigatran moves from mother to fetus
May 14th 2014New research published in Obstetrics & Gynecology indicates the oral thrombin inhibitor, dabigatran, and its prodrug, dabigatran etexilate mesylate transfer from pregnant women to their fetuses via the placenta and could potentially affect fetal blood coagulation.
Greatest impact of pharmacist transition care seen in elderly
May 13th 2014A care transition program for hospital patients with bedside delivery of postdischarge medications and follow-up calls by pharmacists shortly after discharge had the greatest impact on elderly patients, resulting in a lower likelihood of 30-day readmission, according to a report published May 1 in the American Journal of Health-System Pharmacy.